An allergy testing system comprises a skin test device having a grip portion for holding the device. One or more legs extend from the grip, and each leg is oriented to interact with a well containing a potential allergen. Each leg has a test head, and each test head has a plurality of elongated spike members. The elongated spike members have a sharp end configured to receive the potential allergen from a well and to puncture a patient's skin. In addition, each test head has a touch activator. The touch activator is longer than the plurality of elongated spike members, such that during an allergy test, the touch activator comes into contact with the skin prior to the elongated spike members, causing the touch activator to activate nerve tissue that blocks transmission of pain, resulting in a reduction of pain and/or discomfort during testing.

Systems and methods described herein include those for the continual modification of intestinal microbes. Described herein are systems including sampling devices, analysis devices, computational devices and user interface devices as well as methods for the use of such devices in combination.

An allergy test kit including a housing, a biosensor supported by the housing, the biosensor operable to detect a presence of immunoglobin A (IgA) in a sample of sweat of a user and to generate IgA presence data, an allergen sensor supported by the housing, the allergen sensor operable to detect a presence of an allergen in a substance sample provided by the user and to generate allergen presence data, a processor operable to receive the IgA presence data from the biosensor and the allergen presence data from the allergen sensor, and a memory operable to store the IgA presence data and the allergen presence data.

The kit evaluates the patient's skin for penicillin sensitivity. The kit comprises a container, a multi-site skin test system, five preloaded syringes, and a tattoo-type label that is transferable onto the patient's skin. A multi-site skin test applicator is cooperatively engageable with four reservoirs in a fluid tray. The applicator pierces the patient's skin as trace amounts of the allergy test fluids are simultaneously administered. The tattoo-type label is transferable onto the skin of the patient and includes a QR Code. The QR Code includes machine-readable linkage to artificial intelligence for assisting a doctor in interpreting patient test results. The doctor reviews the artificial intelligence analysis and decides either to accept the analysis or modify it. The doctor may also decide to verify negative results with a subcutaneous skin test. The five syringes are preloaded with saline, two syringes are preloaded with Pre-Pen, and two syringes are preloaded with Pen-G.

A sexual stimulation device for applying stimulus to an erogenous zone of the human body. The sexual stimulation device has a body and an interchangeable head that can be interchangeably coupled to the body. The body has a motor. The interchangeable head has a stimulation surface. A kit is also provided having two such bodies and four interchangeable heads. Each of the four interchangeable heads has a different stimulation surface.

A portable source medical device determines communication links of a network presently available to effect communications with a target component when the source medical device is at each of a multiplicity of geographical locations. A profile is generated comprising information about each available communication link and attributes associated with each available communication link for each geographical location. When the source medical device is at a particular geographical location, a profile associated with the particular geographical location is accessed and a network connection is established between the source medical device and the target component using a communication link associated with the particular profile. Medical information is transferred between the source medical device and the target component via the communication link associated with the particular profile.

There is provided a method for use in determining whether a subject is allergic to a substance. The method comprises: receiving a first set of spatially distributed light intensity values covering a skin region of the subject including a location at which the substance has been applied; wherein the light intensity values in the first set are intensities of visible light; receiving a second set of spatially distributed light intensity values covering the skin region, wherein the light intensity values in the second set are intensities of infrared, IR, light; generating a first spatial distribution of photoplethysmogram, PPG, pulse amplitudes based on the first set of light intensity values; generating a second spatial distribution of PPG pulse amplitudes based on the second set of light intensity values; comparing the first spatial distribution to the second spatial distribution, and to the location at which the substance has been applied; and outputting an indication of whether the subject is experiencing an allergic reaction to the substance based on the comparing.

The technology involves scaffold structures used for in-ear sensor systems. Such systems that can perform biometric signal detection or act as a human-computer interface. Scaffolding arrangements minimize the amount of material placed in the ear while providing a secure fitting device that can be worn for hours, days or longer in order to provide maximal benefit to the wearer. The scaffolding includes a “C”-shaped arcuate curvature for at least part of the housing. This configuration can act as a natural leaf spring to help maintain the housing in contact with different points along the ear. Sensors are located along various points of the scaffolding for use in different diagnostic situations. Different components of an on-board sensor input and processing system can be distributed along different parts of the scaffolding. Such structures beneficially minimize ambient sound occlusion and avoid the need of an exterior strap or clip worn around the ear.

A system and method for automatic reading skin for an allergy to a substance, includes a consumer electronics device that acquires images of skin; a consumable member having a surface divided into elementary areas, each elementary area with a different possible allergenic substance; and a palette that, when applied against each elementary area brings the depositing part into contact with the skin thereby depositing the corresponding possible allergenic substance on or under the skin, where an image processing operation of the image of the skin taken by the consumer electronics device localizes the location that each depositing part has deposited the possible allergenic substance during the application and provides information in relation with a sensitivity of the skin, as indicated by a visible reaction, to the possible allergenic substance at each localized location.

A blister strip which can be stuck onto the skin, is formed from at least two sheets and has an applicator for applying a medium contained in the blister to the skin, wherein the blister strip includes an upper sheet, with at least one protuberance, wherein the underside of the upper sheet, the underside enclosing the protuberance, is of adhesive configuration. The blister strip has a lower sheet, which covers the lower surface of the blister strip and can be drawn off from the adhesive underside of the upper sheet. The protuberance contains an applicator, separating the protuberance into at least two sub-volumes. Wherein the applicator has at least one opening, which connects two sub-volumes, wherein one sub-volume is located between the applicator and the lower sheet, and wherein at least one sub-volume is entirely surrounded by the inner surface of the protuberance and the applicator, and contains the medium.